Cancer Letters

Article	Citations
Editorial Board	191
Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells	189
Versatility of Exosomes for Cancer Therapy	181
Bypassing the Tollway; a novel path to TLR4 independent stemness regulation	179
Ethnic Diversity and Metabolic Variations in Ovarian Cancer Cells: Implications for Personalized Medicine Strategies	174
Editorial Board	172
Corrigendum to “Selective degradation of FGFR1/2 overcomes antiestrogen resistance in ER+ breast cancer with FGFR1/2 alterations” [619 1 (2025) 217668 1–13]	158
Corrigendum to “Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1” [Can	146
Corrigendum to “Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells” [Cancer. Lett. (382) 2016-11-28; 382(2):215–230]	146
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?	144
METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth	132
Corrigendum to “The deficiency of ALKBH5 promotes lenvatinib resistance and CD8+ T cell exhaustion via accumulation of the cholesterol metabolite 27HC in hepatocellular carcinoma” [643 10 (2026) 21831	132
Unscheduled polyploidy synergizes with oncogenic mutations to enhance genome instability and tumorigenesis	127
Hormonal and neuronal interactions shaping the brain metastatic microenvironment	123
A novel mismatch repair deficient lung adenocarcinoma model for immunotherapy research	121
TIM3 on natural killer cells regulates antibody-dependent cellular cytotoxicity in HER2-positive gastric cancer	117
ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma	114
Editorial Board	114
Nervous system in colorectal cancer	109
The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes	108
Neutrophil extracellular traps enhance platinum resistance in ovarian cancer via SHP-1 activation	107
Targeting MKK3/c-Myc interaction to overcome osimertinib acquired resistance in EGFR mutant lung cancer	107
A natural compound melatonin enhances the effects of Nimotuzumab via inhibiting EGFR in glioblastoma	105
Regulation of gut microbiota on immune cell ferroptosis: A novel insight for immunotherapy against tumor	103
Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progression	102

EGFR S442 ectodomain mutation confers cetuximab resistance that can be overcome by ERBB2 blockade with trastuzumab-deruxtecan	98
Spatial multi-omics defines cancer-associated fibroblasts subtype gradients driving metabolic support and immune remodeling in pancreatic ductal adenocarcinoma	96
Novel role of MKRN2 in regulating tumor growth through host microenvironment and macrophage M1 to M2 switch	95
LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation	94
Chaperone directed heterobifunctional molecules circumvent KRASG12C inhibitor resistance	92
Increasing membrane polyunsaturated fatty acids sensitizes non-small cell lung cancer to anti-PD-1/PD-L1 immunotherapy	92
Hypoxia effects on glioblastoma progression through YAP/TAZ pathway regulation	92
CD147-specific chimeric antigen receptor T cells effectively inhibit T cell acute lymphoblastic leukemia	91
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy	88
FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity	88
Intratumoral injection of mRNA encoding survivin in combination with STAT3 inhibitor stattic enhances antitumor effects	87
Clinical development of immuno-oncology therapeutics	85
ERBB3 targeting: A promising approach to overcoming cancer therapeutic resistance	83
Fatty acids in cancer chemoresistance	82
Neoantigen discovery and applications in glioblastoma: An immunotherapy perspective	82
M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1	81
Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with minichromosome maintenance complex component 2	80
Manganese mediates nucleoplasm distribution of cGAS to enhance systemic antitumor immunity and drive abscopal effect	80
Dual role of LY96 in shaping the mesenchymal glioblastoma ecosystem through stem cell maintenance and macrophage MES-like reprogramming	79
PROTACs: Novel tools for improving immunotherapy in cancer	79
Tumor-targeted exosomes for delivery of anticancer drugs	78
Evaluation and preservation of fertility in patients with hematologic malignancies	78
Sialic Acids: Sweet modulators fueling cancer cells and domesticating the tumor microenvironment	77
The role of Hippo/YAP1 in cancer-associated fibroblasts: Literature review and future perspectives	77
The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling	76
Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy	75
The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics	75
Targeting FOXM1 reshapes antitumor immunity to attenuate small cell lung cancer progression	74
Proteomics and single cell profiling identify keratin driven preexisting immunity influences lung squamous carcinoma neoadjuvant therapy	74
Targeting p53 for immune modulation: Exploring its functions in tumor immunity and inflammation	73
Accelerating the clinical translation of CD70-targeted chimeric antigen receptor-based cell therapies in oncology: A comprehensive clinical investigation panorama analysis based on the Trialtrove data	73
Tuning cellular metabolism for cancer virotherapy	73
CD155 in tumor progression and targeted therapy	70
Osteopontin promotes tumor microenvironment remodeling and therapy resistance	70
MDSCs in bone metastasis: Mechanisms and therapeutic potential	69
Comparable survival outcomes in HLA-Matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40–50: A CBMTR Registry-based propensity score matching	69
An emerging aspect of cancer neuroscience: A literature review on chemotherapy-induced peripheral neuropathy	68
Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model	68
The landscape of malignant transition: Unraveling cancer cell-of-origin and heterogeneous tissue microenvironment	67
Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer	67
KAT7 enhances the proliferation and metastasis of head and neck squamous carcinoma by promoting the acetylation level of LDHA	66
Letter to the editor on ‘A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer’	65
Targeting Amino Acid Dependency for Cancer Treatment	65
NSUN2-mediated m5C modification of KDM6B mRNA enhances osteoclast differentiation and promotes breast cancer bone metastasis	65
Combination treatment with 17β-estradiol and anti-PD-L1 suppresses MC38 tumor growth by reducing PD-L1 expression and enhancing M1 macrophage population in MC38 colon tumor model	65
AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen depriv	65
Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives	65
An effective two-stage NMBzA-induced rat esophageal tumor model revealing that the FAT-Hippo-YAP1 axis drives the progression of ESCC	65
Extrachromosomal DNA amplifications exhibit distinct molecular characteristics and prognostic implications in gastric cancer	64
R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling	64

Loss of TFAM accelerates pentose phosphate pathway by unleashing G6PD oligomerization to drive hepatocarcinogenesis	64
Corrigendum to “Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway” [Canc. Lett. (2023) 2161	63
BCL-2/BCL-XL dual inhibition triggers Gasdermin D-mediated pyroptosis in mantle cell lymphoma	63
Corrigendum to “UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation” [Canc. Lett. 494 (20	63
Advancing neoadjuvant therapy with inetetamab for HER2-Positive breast cancer	63
Tumor cell derived CCL20 exacerbates the immunosuppressive microenvironment by recruiting CCR6+ Tregs in pancreatic cancer	62
FOXF2 expression triggered by endocrine therapy orchestrates therapeutic resistance through reorganization of chromatin architecture in breast cancer	62
A high-affinity antibody-drug conjugates Actuximab-MMAE for potent and selective targeting of CEACAM5-Positive tumors	61
Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response	61
MLCK inhibition induces synthetic lethality in MYC-driven cancer	60
Lactylation-boosted polycomb repression of KLF4 elicits glycolysis in retinoblastoma: A positive feedback circuit between histone modifications	60
Validation of “SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade” in an independent cohort of 4,407 patients	60
The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma	60
Editorial Board	60
MEK-mediated CHPF2 phosphorylation promotes colorectal cancer cell proliferation and metastasis by activating NF-κB signaling	59
Uncontrolled hyperglycemia-induced membrane cholesterol dysregulation drives tumor immune evasion by reducing hardness of tumor cell plasma membrane	58
Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2→CNTF axis to promote progression of brain metastases	58
Emerging roles of lysosome homeostasis (repair, lysophagy and biogenesis) in cancer progression and therapy	58
LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma	58
G6PD+CSV+ circulating tumor cells associated with portal vein tumor thrombus formation via EMT-ferroptosis crosstalk: a dual biomarker for therapeutic efficacy and prognosis prediction in hepatocellul	58
Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma	57
Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer	57
CircFLNB upregulated by chemotherapy via alternative splicing suppresses the progression of colorectal cancer	56
Glucose restriction induces ROS-AMPK-mediated CTR1 expression and increases cisplatin efficiency in NSCLC	56
Identification and characterization of Bufalin as a novel EGFR degrader	56
Improved antitumor effects elicited by an oncolytic HSV-1 expressing a novel B7H3nb/CD3 BsAb	55
Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity	55
Conquering chemoresistance in pancreatic cancer: Exploring novel drug therapies and delivery approaches amidst desmoplasia and hypoxia	55
ANKZF1 knockdown inhibits glioblastoma progression by promoting intramitochondrial protein aggregation through mitoRQC	55
Obese adipose tissue-derived extracellular vesicles enriched with glycolytic cargo promote colorectal cancer tumorigenesis	55
S100A6 drives lymphatic metastasis of liver cancer via activation of the RAGE/NF-kB/VEGF-D pathway	54
Copper orchestrates triple-negative breast cancer progression via the STEAP3-dependent CDK16-JAK1 activation	54
Unraveling pancreatic ductal adenocarcinoma at single-cell resolution with spatial insights: From mechanisms to clinical translation	53
Mapping the tumor immune landscape: single-cell RNA sequencing in cancer immunotherapy	53
Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity	52
Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort study	52
WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer	52
Tumor-nerve interactions in cancer regulation and progression	52
Exercise in cancer prevention and anticancer therapy: Efficacy, molecular mechanisms and clinical information	52
Single-cell RNA-sequencing of human spleens reveals an IDO-1+ tolerogenic dendritic cell subset in pancreatic cancer patients that is absent in normal individuals	52
Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis	51
Protective role of epithelial deoxyhypusine synthase in colorectal carcinogenesis caused by deletion of the adenomatous polyposis coli gene	51
WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity	51
LINC00978 regulates metabolic rewiring to promote the malignancy of glioblastoma through AKR1B1	51
AI-based radiomic features predict outcomes and the added benefit of chemoimmunotherapy over chemotherapy in extensive stage small cell lung cancer: A multi-institutional study	51
The feedback loop of AURKA/DDX5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer	51
Editorial Board	50
Develop a Novel Therapy for Pancreatic Cancer	50
Editorial Board	50
Editorial Board	50
Antimetastatic activity of B7-H3-targeted CAR T-cell therapy in triple-negative breast cancer	49
A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study	49
Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses	48
Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula	48
Editorial Board	47
Corrigendum to “P-REX1 amplification promotes progression of cutaneous melanomavia the PAK1/P38/MMP-2 pathway” [Cancer Lett. 407 (2017) 66–75]	47
Active immunization with a structurally aggregated PD-L1 antigen breaks T and B immune tolerance in non-human primates and exhibits in vivo anti-tumoral effects in immunocompetent mouse tumor models	47
Shifts in cancer funding: An overview of terminated research grants at the national cancer institute	47
Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression	47
Multi-omics analysis unraveling stemness features associated with oncogenic dedifferentiation in 12 cancers	47
PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivo	47
FUT2-dependent fucosylation of LAMP1 promotes the apoptosis of colorectal cancer cells by regulating the autophagy-lysosomal pathway	46
The CGCG response assessment criteria for spinal cord gliomas	46
Targeting WEE1 kinase as a therapeutic strategy in ATIP3-deficient breast cancers	46
Remodeling of tumor microenvironment by extracellular matrix protein 1a differentially regulates ovarian cancer metastasis	46
Mitochondrial fragmentation in liver cancer: Emerging player and promising therapeutic opportunities	46
Comprehensive clinico-genomic analysis of pancreatic ductal adenocarcinoma: Overcoming biases and limitations	46
The role of the microbiota in cancer drug resistance and emerging therapeutic strategies	46
Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance	46
The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: A phase I trial	46
Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression	45
Mucins as contrast agent targets for fluorescence-guided surgery of pancreatic cancer	45
The post-chemotherapy changes of tumor physical microenvironment: Targeting extracellular matrix to address chemoresistance	45
GPRC5A promotes gallbladder cancer metastasis by upregulating TNS4 via the JAK2–STAT3 pathway	45
Phosphorylation of PBK/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth	45
SENP1-Sirt3 axis promotes cholesterol biosynthesis in tumor-associated macrophages to suppress anti-tumor immunity	44
Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation	44
Exosomal circUBR5 drives metastasis and chemoresistance in gastric signet-ring cell carcinoma by reprogramming cholesterol metabolism through the hsa-miR-1208/CYP19A1 axis and ACAT1 upregulation	44
Decoding the potential microbiome modulation strategies from bugs to drugs in pancreatic cancer: Insights from clinical trials	44
Suppressive immune microenvironment and CART therapy for glioblastoma: Future prospects and challenges	43

CircUBE3A(2,3,4,5) promotes adenylate-uridylate-rich binding factor 1 nuclear translocation to suppress prostate cancer metastasis	43
Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma	43
Phase separation of EEF1E1 promotes tumor stemness via PTEN/AKT-mediated DNA repair in hepatocellular carcinoma	43
Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies	43
Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer	43
Application prospect of circular RNA-based neoantigen vaccine in tumor immunotherapy	43
Dysregulation of autophagy in gastric carcinoma: Pathways to tumor progression and resistance to therapy	43
Nanomaterials in crossroad of autophagy control in human cancers: Amplification of cell death mechanisms	43
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity	43
Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progression	42
Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy	42
hnRNPLL regulates MYOF alternative splicing and correlates with early metastasis in pancreatic ductal adenocarcinoma	42
Disparities in mortality risk after diagnosis of hematological malignancies in 185 countries: A global data analysis	42
Copper in hepatocellular carcinoma： A double-edged sword with therapeutic potentials	42
A journey to excellence: Disseminating groundbreaking discoveries in oncology research	42
Super-giant cells: Toward understanding tumor origins on the organismal level	41
Effective leukemia-to-granulocyte induction by a cocktail of RUNX1, SPI1 and CEBPE	41
The eIF3a translational control axis in the Wnt/β-catenin signaling pathway and colon tumorigenesis	41
Deglycosylated PD-L1 is a biomarker for immune checkpoint blockade response: a real-world study in breast cancer patients in Taiwan	41
Identification of SMARCAL1 as a molecular target for small cell lung cancer treatment	41
Corrigendum to “NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization” [Cancer Lett. (2024) 597 217059]	41
Corrigendum to “Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer” [Cancer Lett. 456 (2019 Aug 1) 1	41
Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer	41
Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer	41
Hepatoprotective role for ERMP1 in MASLD-driven hepatocarcinogenesis and β-catenin-mutated tumors	41
Corrigendum to “Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer” [Canc. Lett. 374 (2016) 292–303]	41
Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses	41
The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma	41
Melanoma cells release dysfunctional mitochondria to the tumor microenvironment and circulation in association with tumor progression	41
A phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling	41
Corrigendum to “The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post- neoadjuvant therapy” [Cancer Lett. (2026), Online ahead of print]	41
RNA methyltransferase METTL16: From molecular mechanisms to therapeutic prospects in cancers	40
Neutrophils exposed to a cholesterol metabolite secrete extracellular vesicles that promote epithelial-mesenchymal transition and stemness in breast cancer cells	40
SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis	40
Identification of SPP1+ macrophages in promoting cancer stemness via vitronectin and CCL15 signals crosstalk in liver cancer	40
Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis	40
CPSF3 regulates alternative polyadenylation of CNIH2 to promote esophageal squamous cell carcinoma progression	40
Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis	40
Targeting ephrin receptor A10 with antibody-drug conjugates for breast cancer	40
Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming	40
Single-nucleus sequencing unveils heterogeneity in renal cell carcinomas microenvironment: Insights into pathogenic origins and treatment-responsive cellular subgroups	39
Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer	39
Keloids revisited: Current concepts in treatment and differential diagnosis	39
CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma	39
Revisiting the advances and challenges in the clinical applications of extracellular vesicles in cancer	39
A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression	39
EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail	39
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer	39
Single-cell transcriptomics reveals intratumor heterogeneity and the potential roles of cancer stem cells and myCAFs in colorectal cancer liver metastasis and recurrence	39
Circadian disruption in cancer and regulation of cancer stem cells by circadian clock genes: An updated review	39
Enhanced prediction of breast cancer patient response to chemotherapy by integrating deconvolved expression patterns of immune, stromal and tumor cells	39
Lipid metabolism reprogramming of CD8+ T cell and therapeutic implications in cancer	39
Editorial Board	38
Corrigendum to “Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma” [Cancer Lett. 449 (2019) 87–98]	38
Editorial Board	38
MFN2-CD36 interaction regulates mitochondrial lipid digestion in cancer-associated fibroblasts and promotes esophageal squamous cell carcinoma progression	38
How to design next-generation of antibody-drug conjugates for cancer treatment: Lessons from unsuccessful clinical trials	38
Integrating multi-omics and artificial intelligence for personalized breast cancer management: A guide to clinicians	38
Editorial Board	38
PPDPF promotes esophageal squamous cell carcinoma progression by blocking PCCA binding to PCCB and inhibiting methionine catabolism	38
Exosomal cannabidiol: A promising candidate for targeted oral delivery against breast cancer	38
Radiosensitization of intrahepatic cholangiocarcinoma and metastatic disease in the liver using microbubble cavitation: results from a phase 2 clinical trial	38
Corrigendum to “Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance” [Cancer Lett. (2018) 412 243–255]	38
The intersections between neuroscience and medulloblastoma	38
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma	38
Targeting the molecular chaperone CCT2 inhibits GBM progression by influencing KRAS stability	38
Editorial Board	37
Multi-functional extracellular vesicles: Potentials in cancer immunotherapy	37
Disruption of enhancer-driven S100A14 expression promotes esophageal carcinogenesis	37
Drug screening reveals differential drug response in primary and metastatic clear cell sarcoma	37
Editorial Board	37
Inflammatory cytokine-regulated LNCPTCTS suppresses thyroid cancer progression via enhancing Snail nuclear export	37
TFAP2C-DDR1 axis regulates resistance to CDK4/6 inhibitor in breast cancer	37
MUC15 loss promotes perineural invasion in pancreatic cancer by activating the IGF1R/STAT3/NGF pathway	37
Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma	37
IgSF protein EWI2 is a tumor suppressor	37
The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinoma	37
Cell adhesion molecule ITGB2 promotes CAR-T cell therapy in B-cell malignancies	37
Dual blockade of PD-1 and CTLA-4 generates long-lasting immunity against irradiated glioblastoma	36
ITGB5 facilitates gastric cancer metastasis by promoting TGFBR2 endosomal recycling	36
Cancer-associated fibroblast-like fibroblasts in vocal fold leukoplakia suppress CD8+T cell functions by inducing IL-6 autocrine loop and interacting with Th17 cells	36
Cancer-associated fibroblasts: A key target to snatch victory from defeat in therapy resistance associated with the pancreatic cancer stroma	36
Loss of branched-chain amino acid (BCAA) metabolism mediated by IGF2BP1-LPAL2-YBX1 interaction promotes malignancy in gallbladder cancer	36
Cancer stem cells and tumor-associated macrophages: Interactions and therapeutic opportunities	36
Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice	36
The new era of pancreatic cancer treatment: Application of nanotechnology breaking through bottlenecks	35
ITPR1-AS1 promotes small cell lung cancer metastasis by facilitating P21 splicing and stabilizing DDX3X to activate the cRaf-MEK-ERK cascade	35
HMGB1 in the interplay between autophagy and apoptosis in cancer	35
SRC at the crossroads of KRAS inhibitor resistance: Mechanisms and therapeutic opportunities	35
TGM2-mediated serotonylation in tumor endothelial cells promotes angiogenesis and tumor growth in colorectal cancer	35
Extracellular vesicle biomarkers redefine prostate cancer radiotherapy	35
Harnessing genetic interactions for prediction of immune checkpoint inhibitors response signature in cancer cells	35
Microbiome and gartynecologic cancer	35
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells	35
ETV4 lysine 2-hydroxyisobutyrylation promotes intrahepatic cholangiocarcinoma progression by suppressing ferroptosis through TXNIP downregulation	35